A business in context
CRNT research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-12 | Makov Efrat | S · Sale | Ordinary Shares | 5000.0 | 2.99 |
| 2026-06-12 | Makov Efrat | M · Exercise / conversion | Ordinary Shares | 5000.0 | 1.99 |
| 2026-06-12 | Makov Efrat | M · Exercise / conversion | Stock Option (Right to Buy) | 5000.0 | 0.0 |
| 2026-06-11 | Arazi Doron Ovadia | A · Grant / award | Ordinary Shares | 66667.0 | 0.0 |
| 2026-06-11 | Arazi Doron Ovadia | A · Grant / award | Stock Option (Right to Buy) | 133333.0 | 0.0 |
| 2026-05-23 | Rosen Ilan | A · Grant / award | Ordinary Shares | 22120.0 | 0.0 |
| 2026-05-23 | Rosen Ilan | A · Grant / award | Stock Option (Right to Buy) | 44240.0 | 0.0 |
| 2026-05-23 | Hadar Rami | A · Grant / award | Ordinary Shares | 14750.0 | 0.0 |
| 2026-05-23 | Hadar Rami | A · Grant / award | Stock Option (Right to Buy) | 29500.0 | 0.0 |
| 2026-05-23 | Makov Efrat | A · Grant / award | Ordinary Shares | 14750.0 | 0.0 |
| 2026-05-23 | Makov Efrat | A · Grant / award | Stock Option (Right to Buy) | 29500.0 | 0.0 |
| 2026-05-23 | WADSWORTH ROBERT M | A · Grant / award | Ordinary Shares | 14100.0 | 0.0 |
| 2026-05-23 | WADSWORTH ROBERT M | A · Grant / award | Stock Option (Right to Buy) | 28200.0 | 0.0 |
| 2026-05-23 | Ripstein David | A · Grant / award | Ordinary Shares | 14750.0 | 0.0 |
| 2026-05-23 | Ripstein David | A · Grant / award | Stock Option (Right to Buy) | 29500.0 | 0.0 |
| 2026-05-23 | Liran Shlomo | A · Grant / award | Ordinary Shares | 14750.0 | 0.0 |
| 2026-05-23 | Liran Shlomo | A · Grant / award | Stock Option (Right to Buy) | 29500.0 | 0.0 |
| 2026-05-23 | Shaham Yael | A · Grant / award | Ordinary Shares | 14750.0 | 0.0 |
| 2026-05-23 | Shaham Yael | A · Grant / award | Stock Option (Right to Buy) | 29500.0 | 0.0 |
| 2026-05-22 | Rosen Ilan | A · Grant / award | Ordinary Shares | 9770.0 | 0.0 |
| 2026-05-22 | Rosen Ilan | A · Grant / award | Stock Option (Right to Buy) | 19540.0 | 0.0 |
| 2026-05-22 | Hadar Rami | A · Grant / award | Ordinary Shares | 6520.0 | 0.0 |
| 2026-05-22 | Hadar Rami | A · Grant / award | Stock Option (Right to Buy) | 13030.0 | 0.0 |
| 2026-05-22 | Makov Efrat | S · Sale | Ordinary Shares | 6667.0 | 2.65 |
| 2026-05-22 | Makov Efrat | M · Exercise / conversion | Ordinary Shares | 6667.0 | 2.11 |
| 2026-05-22 | Makov Efrat | A · Grant / award | Ordinary Shares | 6520.0 | 0.0 |
| 2026-05-22 | Makov Efrat | M · Exercise / conversion | Stock Option (Right to Buy) | 6667.0 | 0.0 |
| 2026-05-22 | Makov Efrat | A · Grant / award | Stock Option (Right to Buy) | 13030.0 | 0.0 |
| 2026-05-22 | WADSWORTH ROBERT M | A · Grant / award | Ordinary Shares | 6530.0 | 0.0 |
| 2026-05-22 | WADSWORTH ROBERT M | A · Grant / award | Stock Option (Right to Buy) | 13050.0 | 0.0 |
| 2026-05-22 | Ripstein David | A · Grant / award | Ordinary Shares | 6520.0 | 0.0 |
| 2026-05-22 | Ripstein David | A · Grant / award | Stock Option (Right to Buy) | 13030.0 | 0.0 |
| 2026-05-22 | Liran Shlomo | A · Grant / award | Ordinary Shares | 6520.0 | 0.0 |
| 2026-05-22 | Liran Shlomo | A · Grant / award | Stock Option (Right to Buy) | 13030.0 | 0.0 |
| 2026-05-22 | Shaham Yael | A · Grant / award | Ordinary Shares | 6520.0 | 0.0 |
| 2026-05-22 | Shaham Yael | A · Grant / award | Stock Option (Right to Buy) | 13030.0 | 0.0 |
Identity & relationships
SEC issuer · 0001119769CERAGON NETWORKS LTD
Ceragon (Norway)
Search names and former names
View Wikidata identity and references ↗
- Ceragon · alias · wikidata
- Ceragon Networks · alias · wikidata
- Ceragon (Norway) · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $394.19M | $419.60M |
| 2023-12-31 | $347.18M | $380.44M |
| 2022-12-31 | $295.17M | $336.74M |
| 2021-12-31 | $290.77M | $358.25M |
| 2020-12-31 | $262.88M | $339.17M |
| 2019-12-31 | $285.58M | $372.98M |
| 2018-12-31 | $343.87M | $457.26M |
| 2017-12-31 | $332.03M | $452.31M |